Annual FCF
-$230.18 M
-$58.42 M-34.01%
December 31, 2023
Summary
- As of February 7, 2025, SWTX annual free cash flow is -$230.18 million, with the most recent change of -$58.42 million (-34.01%) on December 31, 2023.
- During the last 3 years, SWTX annual FCF has fallen by -$197.35 million (-601.06%).
- SWTX annual FCF is now -1491.95% below its all-time high of -$14.46 million, reached on December 31, 2018.
Performance
SWTX Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly FCF
-$27.23 M
+$26.79 M+49.60%
September 30, 2024
Summary
- As of February 7, 2025, SWTX quarterly free cash flow is -$27.23 million, with the most recent change of +$26.79 million (+49.60%) on September 30, 2024.
- Over the past year, SWTX quarterly FCF has increased by +$26.79 million (+49.60%).
- SWTX quarterly FCF is now -281.36% below its all-time high of $15.01 million, reached on December 31, 2020.
Performance
SWTX Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM FCF
-$221.15 M
+$26.86 M+10.83%
September 30, 2024
Summary
- As of February 7, 2025, SWTX TTM free cash flow is -$221.15 million, with the most recent change of +$26.86 million (+10.83%) on September 30, 2024.
- Over the past year, SWTX TTM FCF has increased by +$26.86 million (+10.83%).
- SWTX TTM FCF is now -2873.26% below its all-time high of -$7.44 million, reached on March 31, 2019.
Performance
SWTX TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
SWTX Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -34.0% | +49.6% | +10.8% |
| 3 y3 years | -601.1% | +49.6% | +10.8% |
| 5 y5 years | -1492.0% | +49.6% | +10.8% |
SWTX Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -77.2% | at low | -17.7% | +65.8% | -70.3% | +10.8% |
| 5 y | 5-year | -601.1% | at low | -281.4% | +65.8% | -573.6% | +10.8% |
| alltime | all time | -1492.0% | at low | -281.4% | +65.8% | -2873.3% | +10.8% |
SpringWorks Therapeutics Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$27.23 M(-49.6%) | -$221.15 M(-10.8%) |
| Jun 2024 | - | -$54.02 M(-32.1%) | -$248.01 M(+1.3%) |
| Mar 2024 | - | -$79.51 M(+31.6%) | -$244.89 M(+6.4%) |
| Dec 2023 | -$230.18 M(+34.0%) | -$60.40 M(+11.7%) | -$230.18 M(+2.0%) |
| Sep 2023 | - | -$54.08 M(+6.3%) | -$225.73 M(+15.9%) |
| Jun 2023 | - | -$50.90 M(-21.4%) | -$194.78 M(+5.0%) |
| Mar 2023 | - | -$64.80 M(+15.8%) | -$185.48 M(+8.0%) |
| Dec 2022 | -$171.76 M(+32.2%) | -$55.96 M(+141.9%) | -$171.76 M(+5.0%) |
| Sep 2022 | - | -$23.13 M(-44.4%) | -$163.62 M(-2.5%) |
| Jun 2022 | - | -$41.60 M(-18.6%) | -$167.75 M(+5.0%) |
| Mar 2022 | - | -$51.08 M(+6.8%) | -$159.82 M(+23.0%) |
| Dec 2021 | -$129.89 M | -$47.82 M(+75.4%) | -$129.89 M(+93.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2021 | - | -$27.26 M(-19.0%) | -$67.06 M(+22.7%) |
| Jun 2021 | - | -$33.66 M(+59.2%) | -$54.66 M(+46.1%) |
| Mar 2021 | - | -$21.15 M(-240.9%) | -$37.42 M(+14.0%) |
| Dec 2020 | -$32.83 M(-31.8%) | $15.01 M(-201.0%) | -$32.83 M(-48.7%) |
| Sep 2020 | - | -$14.87 M(-9.5%) | -$63.95 M(+6.1%) |
| Jun 2020 | - | -$16.42 M(-0.8%) | -$60.28 M(+5.3%) |
| Mar 2020 | - | -$16.56 M(+2.8%) | -$57.23 M(+19.0%) |
| Dec 2019 | -$48.11 M(+232.8%) | -$16.10 M(+43.8%) | -$48.11 M(+50.3%) |
| Sep 2019 | - | -$11.20 M(-16.3%) | -$32.01 M(+53.8%) |
| Jun 2019 | - | -$13.38 M(+79.8%) | -$20.81 M(+179.8%) |
| Mar 2019 | - | -$7.44 M | -$7.44 M |
| Dec 2018 | -$14.46 M | - | - |
FAQ
- What is SpringWorks Therapeutics annual free cash flow?
- What is the all time high annual FCF for SpringWorks Therapeutics?
- What is SpringWorks Therapeutics annual FCF year-on-year change?
- What is SpringWorks Therapeutics quarterly free cash flow?
- What is the all time high quarterly FCF for SpringWorks Therapeutics?
- What is SpringWorks Therapeutics quarterly FCF year-on-year change?
- What is SpringWorks Therapeutics TTM free cash flow?
- What is the all time high TTM FCF for SpringWorks Therapeutics?
- What is SpringWorks Therapeutics TTM FCF year-on-year change?
What is SpringWorks Therapeutics annual free cash flow?
The current annual FCF of SWTX is -$230.18 M
What is the all time high annual FCF for SpringWorks Therapeutics?
SpringWorks Therapeutics all-time high annual free cash flow is -$14.46 M
What is SpringWorks Therapeutics annual FCF year-on-year change?
Over the past year, SWTX annual free cash flow has changed by -$58.42 M (-34.01%)
What is SpringWorks Therapeutics quarterly free cash flow?
The current quarterly FCF of SWTX is -$27.23 M
What is the all time high quarterly FCF for SpringWorks Therapeutics?
SpringWorks Therapeutics all-time high quarterly free cash flow is $15.01 M
What is SpringWorks Therapeutics quarterly FCF year-on-year change?
Over the past year, SWTX quarterly free cash flow has changed by +$26.79 M (+49.60%)
What is SpringWorks Therapeutics TTM free cash flow?
The current TTM FCF of SWTX is -$221.15 M
What is the all time high TTM FCF for SpringWorks Therapeutics?
SpringWorks Therapeutics all-time high TTM free cash flow is -$7.44 M
What is SpringWorks Therapeutics TTM FCF year-on-year change?
Over the past year, SWTX TTM free cash flow has changed by +$26.86 M (+10.83%)